← back to search

Nataly Kravchenko‐Balasha

Hebrew University of Jerusalem · IL
Area of research
Computational Theory and Mathematics · Molecular Biology
Research interest
Research interests include Cancer, Medicine, Biology, Computational biology, Personalized medicine, and Glioblastoma.
h-index
citations
599
works
29
NIH funding
primary concept
email

Recent publications

Effective head and neck cancer treatment combines radiation and local extended cisplatin release
Journal of Controlled Release 2025cited by 3position: lastdoi
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns
npj Precision Oncology 2025cited by 2position: lastdoi
Molecular Changes in Breast Cancer Induced by Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics 2024cited by 12position: middledoi
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Molecular Cancer 2024cited by 12position: lastdoi
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia
npj Systems Biology and Applications 2024cited by 3position: lastdoi
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
International Journal of Molecular Sciences 2023cited by 58position: lastdoi
Paclitaxel Delivery to the Brain for Glioblastoma Treatment
International Journal of Molecular Sciences 2023cited by 26position: middledoi
The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer
Frontiers in Oral Health 2023cited by 10position: lastdoi
Overexpressed kinetochore genes are used by cancer cells as genome destabilizers and transformation catalysts
Translational Oncology 2023cited by 8position: middledoi
Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
Theranostics 2022cited by 24position: lastdoi
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
Genome Medicine 2022cited by 18position: lastdoi
Prescriptomics: the next frontier in medicine
Journal of Integrated OMICS 2022cited by 2position: middledoi
Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations
npj Precision Oncology 2021cited by 29position: lastdoi
Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures
Cancers 2021cited by 28position: lastdoi
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
npj Breast Cancer 2021cited by 20position: middledoi
Explant Modeling of the Immune Environment of Head and Neck Cancer
Frontiers in Oncology 2021cited by 11position: middledoi
Dissecting the role of crosstalk between glioblastoma subpopulations in tumor cell spreading
Oncogenesis 2020cited by 16position: lastdoi
Translating Cancer Molecular Variability into Personalized Information Using Bulk and Single Cell Approaches
PROTEOMICS 2020cited by 12position: firstdoi
HU308 Mitigates Osteoarthritis by Stimulating Sox9-Related Networks of Carbohydrate Metabolism
Journal of Bone and Mineral Research 2020cited by 9position: middledoi
Exploring Alzheimer’s Disease Molecular Variability via Calculation of Personalized Transcriptional Signatures
Biomolecules 2020cited by 8position: lastdoi
Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy
Theranostics 2019cited by 43position: lastdoi
Personalized disease signatures through information-theoretic compaction of big cancer data
Proceedings of the National Academy of Sciences 2018cited by 25position: lastdoi
A thermodynamic-based approach for the resolution and prediction of protein network structures
Chemical Physics 2018cited by 12position: lastdoi
Intercellular signaling through secreted proteins induces free-energy gradient-directed cell movement
Proceedings of the National Academy of Sciences 2016cited by 50position: firstdoi
Critical Points in Tumorigenesis: A Carcinogen‐Initiated Phase Transition Analyzed via Single‐Cell Proteomics
Small 2016cited by 23position: middledoi
A Thermodynamic-Based Interpretation of Protein Expression Heterogeneity in Different Glioblastoma Multiforme Tumors Identifies Tumor-Specific Unbalanced Processes
The Journal of Physical Chemistry B 2016cited by 13position: firstdoi
Glioblastoma cellular architectures are predicted through the characterization of two-cell interactions
Proceedings of the National Academy of Sciences 2014cited by 54position: firstdoi
Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means
PLoS ONE 2013cited by 9position: middledoi
On a fundamental structure of gene networks in living cells
Proceedings of the National Academy of Sciences 2012cited by 59position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Swetha Vasudevan · Hebrew University of Jerusalem10 papers (2018–2024)Ariel M. Rubinstein · Hebrew University of Jerusalem8 papers (2020–2025)Efrat Flashner-Abramson · Hebrew University of Jerusalem7 papers (2018–2022)R. D. Levine · University of California, Los Angeles6 papers (2012–2018)Shay Sharon · Hebrew University of Jerusalem5 papers (2021–2025)Sangita Roy Chowdhury · Hebrew University of Jerusalem5 papers (2021–2024)James R. Heath · Sandia National Laboratories4 papers (2014–2016)Heba Alkhatib · Hebrew University of Jerusalem4 papers (2021–2024)Ibukun Adesoji Adejumobi · Hebrew University of Jerusalem4 papers (2019–2021)Maria R. Jubran · Hebrew University of Jerusalem4 papers (2020–2022)F. Remacle · Hebrew University of Jerusalem3 papers (2012–2018)Shira Stefansky · Hebrew University of Jerusalem3 papers (2021–2022)Michael J. Gough · University Medical Center3 papers (2021–2025)Amichay Meirovitz · Soroka Medical Center3 papers (2022–2024)Daniela Vilenski · Hebrew University of Jerusalem3 papers (2021–2024)Narmeen Daher-Ghanem · Hebrew University of Jerusalem3 papers (2023–2025)Forest M. White · Center for Cancer Research3 papers (2016–2024)Amir Sonnenblick · Ariel University3 papers (2019–2024)Abraham J. Domb · Hebrew University of Jerusalem2 papers (2023–2025)Eli Reich · Hebrew University of Jerusalem2 papers (2020–2023)